Detalles de la búsqueda
1.
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150.
Br J Cancer
; 126(1): 42-47, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711947
2.
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.
Oncologist
; 26(7): 562-568, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914991
3.
Regarding the Article by Rugo et al.
Oncologist
; 26(7): e1285, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818868
4.
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy.
Transl Lung Cancer Res
; 11(3): 432-439, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35399575
5.
A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinoma.
Cancer Chemother Pharmacol
; 89(4): 479-485, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35226112
6.
Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control Trials.
J Thorac Oncol
; 17(6): 758-767, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183773
7.
Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine Exposure.
AAPS J
; 23(1): 15, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33404848
8.
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib.
Breast
; 58: 57-62, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906086
Resultados
1 -
8
de 8
1
Próxima >
>>